These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9061762)

  • 1. The stability of hCG and free beta-subunit in serum samples.
    Kardana A; Cole LA
    Prenat Diagn; 1997 Feb; 17(2):141-7. PubMed ID: 9061762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human chorionic gonadotropin beta-subunit nicking enzymes in pregnancy and cancer patient serum.
    Kardana A; Cole LA
    J Clin Endocrinol Metab; 1994 Sep; 79(3):761-7. PubMed ID: 7521352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deactivation of hCG by nicking and dissociation.
    Cole LA; Kardana A; Park SY; Braunstein GD
    J Clin Endocrinol Metab; 1993 Mar; 76(3):704-10. PubMed ID: 8445030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
    Spencer K; Noble P; Snijders RJ; Nicolaides KH
    Prenat Diagn; 1997 Jun; 17(6):525-38. PubMed ID: 9203211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hCG and the free beta-subunit as screening tests for Down syndrome.
    Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
    Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free beta-hCG subunit versus intact hCG in Down syndrome screening.
    Wenstrom KD; Owen J; Chu DC; Boots L
    Obstet Gynecol; 1997 Sep; 90(3):370-4. PubMed ID: 9277646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant results in human chorionic gonadotropin assays.
    Cole LA; Kardana A
    Clin Chem; 1992 Feb; 38(2):263-70. PubMed ID: 1371722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies.
    Cole LA; Kellner LH; Isozaki T; Palomaki GE; Iles RK; Walker RP; Ozaki M; Canick JA
    Prenat Diagn; 1997 Jul; 17(7):607-14. PubMed ID: 9249860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-marker serum screening for Down's syndrome.
    Wald NJ; Densem JW; Smith D; Klee GG
    Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
    Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
    Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.
    Cole LA; Kardana A; Andrade-Gordon P; Gawinowicz MA; Morris JC; Bergert ER; O'Connor J; Birken S
    Endocrinology; 1991 Sep; 129(3):1559-67. PubMed ID: 1714836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thermal instability of intact human chorionic gonadotropin (ihCG) on the application of its free beta-subunit (free beta hCG) as a serum marker in Down syndrome screening.
    Sancken U; Bahner D
    Prenat Diagn; 1995 Aug; 15(8):731-8. PubMed ID: 7479591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome.
    Brambati B; Tului L; Bonacchi I; Shrimanker K; Suzuki Y; Grudzinskas JG
    Prenat Diagn; 1994 Nov; 14(11):1043-7. PubMed ID: 7533285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit.
    Kardana A; Cole LA
    Clin Chem; 1992 Jan; 38(1):26-33. PubMed ID: 1370771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
    Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
    Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.